GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
50.33
-0.08 (-0.16%)
Nov 6, 2026, 4:00 PM EST - Market closed

GSK Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4,3515,7162,5754,92814,9564,385
Depreciation & Amortization
1,4532,0942,3402,2942,1472,122
Other Amortization
220220211---
Loss (Gain) From Sale of Assets
-40-40-159-12-221-586
Asset Writedown & Restructuring Costs
2,5911,143369360198498
Loss (Gain) From Sale of Investments
-4-4-16-1-128
Loss (Gain) on Equity Investments
10-1352-33
Stock-Based Compensation
374374344307346343
Other Operating Activities
-489141631-257-9,435-804
Change in Accounts Receivable
-613-613298-794-158-780
Change in Inventory
-140-140-294-424-26951
Change in Accounts Payable
131131-179-15494229
Change in Other Net Operating Assets
1,074-1,280431377-1,425824
Operating Cash Flow
8,9187,7416,5546,7687,4037,952
Operating Cash Flow Growth
14.45%18.11%-3.16%-8.58%-6.90%-5.79%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,496-1,348-1,399-1,314-1,143-950
Sale of Property, Plant & Equipment
46246528146132
Cash Acquisitions
-9,386-1,709-824-1,468-3,187-114
Divestitures
248-27-1849-43-17
Sale (Purchase) of Intangibles
-799-1,522-1,452-1,018-919-1,063
Investment in Securities
1671082,2311,78295334
Other Investing Activities
324241168346-3,721-99
Investing Cash Flow
-10,896-4,233-1,229-1,595-8,772-1,777

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1,215266-1,021301
Long-Term Debt Issued
-1,9791,0752231,025-
Total Debt Issued
8,3423,1941,3412232,046301
Short-Term Debt Repaid
--288-892-333--2,304
Long-Term Debt Repaid
--1,641-1,841-2,457-6,870-181
Lease Payments
-227-241-226-197-202-181
Total Debt Repaid
-2,049-1,929-2,733-2,790-6,870-2,485
Net Debt Issued (Repaid)
6,2931,265-1,392-2,567-4,824-2,184
Issuance of Common Stock
101520102521
Repurchase of Common Stock
-886-1,377----
Common Dividends Paid
-2,698-2,564-2,444-2,247-3,467-3,999
Other Financing Activities
-782-1,024-910-8379,089-1,427
Financing Cash Flow
1,937-3,685-4,726-5,641823-7,589

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-80-19-54-99152-29
Net Cash Flow
-78-196545-567-394-1,443

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7,4226,3935,1555,4546,2607,002
Free Cash Flow Growth
14.66%24.02%-5.48%-12.88%-10.60%-6.04%
Free Cash Flow Margin
22.13%19.57%16.43%17.98%21.35%28.35%
Free Cash Flow Per Share
1.821.551.251.331.531.73
Levered Free Cash Flow
5,5543,2844,9543,8374,2664,847
Unlevered Free Cash Flow
5,9993,6955,3394,2814,7785,323
Free Cash Flow After Leases
7,1956,1524,9295,2576,0586,821

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
726679632766848772
Cash Income Tax Paid
1,1491,2021,3071,3281,310972
Change in Working Capital
452-1,902256-856-1,358324
SEC Filings: 10-K · 10-Q